Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Scleroderma Patients Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Scleroderma Patients conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Scleroderma Patients Clinical research trials and Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Scleroderma Patients healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Scleroderma Patients. Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Scleroderma Patients Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Scleroderma Patients clinical trial. Test subjects typically receive the most effective healthcare possible for their Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Scleroderma Patients condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.

Home > "E" Clinical Trials Conditions > Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Scleroderma Patients

Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Scleroderma Patients



Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Scleroderma Patients

For Condition: Systemic Sclerosis,Scleroderma
Status: Recruiting
Sponsor(s): Actelion ,
Synopsis: To date, one clinical trial, RAPIDS-1, was performed in Scleroderma patients with or without digital ulcers at baseline. The RAPIDS-1 study results showed that Bosentan significantly reduced the number of new digital ulcers versus placebo. The purpose of this trial is to evaluate the prevention and healing effects of bosentan versus placebo on digital ulcers over a 24 week treatment period.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Main Inclusion Criteria: - Systemic Sclerosis (SSc), diffuse or limited - SSc patients with at least one digital ulcer at baseline qualifying as a cardinal ulcer. Main Exclusion Criteria: - Digital ulcers due to conditions other than SSc. - Severe pulmonary arterial hypertension (PAH) (Who class III and IV). - Malabsorption or any severe organ failure (e.g., lung, kidney, liver) or any life- threatening condition. - Treatment with parenteral prostanoids (prostaglandin E, epoprostenol, or prostacyclin analogs) during the past 3 months prior to randomization. - Treatment with inhaled or oral prostanoids one month prior to randomization. - Previous treatment with bosentan.
Total Enrollment: 180

Location and Contact Information:

Mittie Doyle, MD *Recruiting*
New Orleans,  Louisiana,  70112
United States
Recruiting Melanie  Larrieu 504-587-7620

Bashar Kahaleh, MD *Recruiting*
Toledo,  Ohio,  43614
United States
Recruiting Carol  Albright 419-383-5299

Michael Ellman, MD *Recruiting*
Chicago,  Illinois,  60637
United States
Recruiting Shahnaz  Kazi 773-702-2645

Frederick Wigley, MD *Recruiting*
Baltimore,  Maryland,  21224
United States
Recruiting Edrick  Forbes 510-550-8582

Joseph Korn, MD *Recruiting*
Boston,  Massachusetts,  02118-2394
United States
Recruiting Kimberly  Tobin 617-638-7503

Richard Martin, MD *Recruiting*
Grand Rapids,  Michigan,  49503
United States
Recruiting Melissa  VanDyken 616-459-8088

Thomas Medsger, MD *Not yet recruiting*
Pittsburgh,  Pennsylvania,  15261
United States
Not yet recruiting Carol  Blair 412-383-8672

Howard Kenney, MD *Recruiting*
Spokane,  Washington,  99204
United States
Recruiting Chiara  Reillo 509-838-6500

Daniel Furst, MD *Recruiting*
Los Angeles,  California,  90095-1670
United States
Recruiting Tina  Burger 310-825-3061

Edwin Smith, MD *Recruiting*
Charleston,  South Carolina,  29425
United States
Recruiting Katie  Caldwell 843-792-2014

Jerry Molitor, MD *Recruiting*
Seattle,  Washington,  98101
United States
Recruiting Carey  Edwards 206-223-6836

Avram Goldberg, MD *Recruiting*
Manhasset,  New York,  11030
United States
Recruiting Cerdi  Beltre 516-562-3732

Lee Shapiro, MD *Recruiting*
Albany,  New York,  12206
United States
Recruiting Christine  Barr 518-533-1324

Barri Fessler, MD *Recruiting*
Birmingham,  Alabama,  35249-7201
United States
Recruiting Paula  McKenzie 205-934-2981

Vivien Hsu, MD *Recruiting*
New Brunswick,  New Jersey,  08903
United States
Recruiting Julianne  Wilson 732-235-7862

Thomas Osborn, MD *Recruiting*
Rochester,  Minnesota,  55905
United States
Recruiting Jane  Jaquith 507-284-4502

Mary Ellen Csuka, MD *Recruiting*
Milwaukee,  Wisconsin,  53211
United States
Recruiting Jovanka  Zrnic 414-456-7022

Chris Derk, MD *Recruiting*
Philadelphia,  Pennsylvania,  19107
United States
Recruiting John  Furlong 215-955-1266

Eric Rich, MD *Recruiting*
Montreal,  Quebec,  H2L 4M1
Canada
Recruiting Diane  Therrien 514-890-8000

Peter Lee, MD *Not yet recruiting*
Toronto,  Ontario,  M5G 1X5
Canada
Not yet recruiting Judi  Guthrie 416-586-8616

David Collier, MD *Recruiting*
Aurora,  Colorado,  80010
United States
Recruiting Janice  Wagner 720-848-1958

Janet Pope, MD *Recruiting*
London,  Ontario,  N6A 4V2
Canada
Recruiting Donna  McBain 519-646-6000

Naomi Rothfield, MD *Recruiting*
Farmington,  Connecticut,  06030-1310
United States
Recruiting Frances  Ingenito 860-679-2589

Murray Baron, MD *Recruiting*
Montreal,  Quebec,  H3T1E2
Canada
Recruiting Maura  Buchignani 514-340-8231

Maureen Mayes, MD *Recruiting*
Houston,  Texas,  77030
United States
Recruiting Samantha  Jordan 713-500-7118


Additional Information:
Study ID Numbers:
  RAPIDS-2 / AC-052-331; 
Study Start Date: September 2003
Record last reviewed: May 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00077584

Other Scleroderma Studies:
1. Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis

2. Psychological Treatments for Scleroderma

3. Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders

4. Scleroderma Registry

5. Stem Cell Transplant to Treat Patients with Systemic Sclerosis

Related Studies:

Other Scleroderma Clinical Trials
Other New York Clinical Trials
Other Manhasset Clinical Trials

Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Scleroderma Patients

Modify your Search

  Other Scleroderma Clinical Trials
  Other New York Clinical Trials
  Other Manhasset Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103